hsa_circ_0001946 (CDR1as/CIRS-7) |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation, migration, and invasion |
miR-7/FAK
|
Diagnosis, disease progression, and targeted therapy |
[104] |
hsa_circ8924 |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes migration and invasion |
miR-518d-5p/CBX8
|
Diagnosis, disease progression, and targeted therapy |
[105] |
hsa_circ_000284(circHIPK3) |
Cervical cancer and normal cell lines |
Up |
Oncogene: promotes proliferation and invasion |
miR-506/SNAI2
|
Diagnosis, and prognosis |
[106,107] |
hsa_circ_0000263 |
Cervical cancer and normal cell lines |
Up |
Oncogene: promotes proliferation, migration and cell cycle, and inhibits apoptosis |
miR-150-5p/MDM4
|
Diagnosis, and treatment |
[108] |
hsa_circ_0132980 (circSLC26A4) |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation and invasion |
miR-1287-5p/HOXA7
|
Disease progression, and targeted therapy |
[109] |
hsa_circ_0000745 |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation, migration, and invasion |
E-cadherin/Vimentin |
Prognosis, and targeted therapy |
[110] |
hsa_circ_0018289 |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation, migration, and invasion |
miR-497 |
Early disease detection |
[111] |
hsa_circ_0101996 |
Cervical cancer and adjacent normal tissues, and peripheral blood of cervical cancer patients and healthy subjects |
Up |
Oncogene: activates cancer progression |
MAPK signaling |
Diagnosis |
[112] |
hsa_circ_0101119 |
Cervical cancers and adjacent normal tissues, and peripheral blood of cervical cancer patients and healthy subjects |
Up |
Oncogene: activates cancer progression |
MAPK signaling |
Diagnosis |
[112] |
hsa_circ_0001445 (cSMARCA5) |
Cervical cancers and adjacent normal tissues, and cervical cancer and normal cell lines |
Up |
Oncogene: promotes proliferation, migration, and invasion |
miR-432/EGFR/ERK1-ERK2
|
Disease progression |
[113] |
hsa_circ_101996 |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation, migration, and invasion |
miR-8075/TPX2
|
Disease progression |
[114] |
hsa_circ_0023404 |
Cervical cancers and adjacent normal tissues |
Up |
Oncogene: promotes proliferation, migration, and invasion |
miR-136/TFCP2/YAP
|
Targeted therapy |
[115] |
hsa_circ_0024169 |
Vaginal carcinoma cell lines |
Up |
Unknown |
Unknown |
Unknown |
[122] |
circE7 |
Anal cancers and adjacent normal tissues |
Up |
Unknown |
Unknown |
Prognosis |
[87] |
hsa_circ_0055538 |
Oral cancers and adjacent normal tissues, and tongue cancer cell lines(HPV-negatives) |
Down |
Tumor suppressor: inhibits proliferation, migration, and invasion, promotes apoptosis |
TP53/BCL2/CASP3
|
Diagnosis, prognosis, and targeted therapy |
[154] |
hsa_circ_0008309 |
Oral cancers and adjacent normal tissues, and tongue cancer cell lines (HPV-negatives) |
Down |
Tumor suppressor: inhibits proliferation, migration, invasion, and EMT |
miR-136-5p/miR-382-5p/ATXN1
|
Diagnosis |
[155] |
hsa_circ_081069 |
Oral cancer and adjacent normal tissues, and tongue cancer cell lines (HPV-negatives) |
Up |
Oncogene: promotes proliferation and migration |
miR-665 |
Diagnosis, and targeted therapy |
[148] |
hsa_circ_0001821 (circPVT1) |
Head and neck cancers and adjacent normal tissues, and pharinx and tongue cancer cell lines (HPV-negatives) |
Up |
Oncogene: promotes proliferation |
miR-497-5p/AURKA/BUB1
|
Diagnosis, and targeted therapy |
[151] |
hsa_circ_0001742 |
Oral cancers and adjacent normal tissues, and tongue cancer cell lines (HPV-negatives) |
Up |
Oncogene: promotes proliferation, migration, invasion, and EMT |
miR-634/RAB1A
|
Prognosis |
[160,161] |